Advertisement

Incidence and impact of anemia in radiation oncology

  • Jürgen Dunst
  • M. Molls

Abstract

About 45 years ago, Thomlinson and Gray (1955) demonstrated the presence of radioresistant hypoxic cells in experimental cancers. Their work stimulated much clinical and experimental research work on hypoxia in tumors. In subsequent investigations, a marked impact of hemoglobin levels on treatment outcome was found by Evans and Bergsjö in 1965. They found a stage-dependent linear relationship between hemoglobin levels and local control as well as survival after radiotherapy. Evans and Bergsjö interpreted their findings as a result of anemia-induced tumor hypoxia. Although numerous other studies have further supported an association between anemia and decreased local control and survival in radiotherapy patients, some controversies have remained and most radiotherapists did not focus on the prognostic impact of anemia in daily work. The main question over the recent years has concentrated on whether or not the well-known association between anemia and survival reflects a causal relationship or represents only an epiphenomemon (Fyles et al. 2000).

Keywords

Cervical Cancer Hemoglobin Level Radiation Oncology Prognostic Impact Radiation Therapy Oncology Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Becker A, Stadler P, Lavey R Haensgen G, Kuhnt T, Lautenschlaeger C, Feldmann HJ, Molls M, Dunst J (2000) Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 46: 459–466PubMedCrossRefGoogle Scholar
  2. Bush RS (1986) The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 12: 2047–2050PubMedCrossRefGoogle Scholar
  3. Canaday DJ, Regine WF, Mohiuddin M, Zollinger W, Machtay M, Schultz D, Rudoltz MS (1999) Significance of pretreatment hemoglobin levels in patients with T1 glottic cancer. Radiat Oncol Investig 7: 42–48PubMedCrossRefGoogle Scholar
  4. Dunst J, Hintner A, Haensgen G, Becker A (1999) Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor ( VEGF) in cancer patients. Does anemia stimulate angiogenesis? Strahlenther Onkol 175: 93–96PubMedCrossRefGoogle Scholar
  5. Evans IC, Bergsjo P (1965) The influence of anemia on the results of radiotherapy in carcinoma of the cervix. Radiology 84: 709–717PubMedGoogle Scholar
  6. Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr, Coia LR (1995) Pretreatment hemoglobin level influences local control and survival of T1–T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 13: 2077–2083PubMedGoogle Scholar
  7. Frommhold H, Guttenberger R, Henke M (1998) The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther Onkol 174 (Suppl IV): 31–34PubMedGoogle Scholar
  8. Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP (2000) Anemia, hypoxia and transfusion in patients with cervical cancer: a review. Radiother Oncol 57: 13–19PubMedCrossRefGoogle Scholar
  9. Girinksi T, Pejovic-Lenfant MH, Bourhis J, Campana F, Cosset JM, Petit C, Malaise EP, Haie C, Gerbaulet A, Chassagne D (1989) Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 16: 37–42CrossRefGoogle Scholar
  10. Grau C, Overgaard J (1998) Significance of hemoglobin concentrations for treatment outcome. In: Molls M, Vaupel P (eds) Blood perfusion and microenvironment of human tumors. Implications for clinical radiooncology. Springer, Berlin, pp 101–112CrossRefGoogle Scholar
  11. Grogan M, Thomas GM, Melamed I, Wong FL (1999) The importance of maintaining high hemoglobin levels during radiation treatment of carcinoma of the cervix. Cancer 86: 1531–1536CrossRefGoogle Scholar
  12. Hannisdal E, Fossa SD, Host H (1993) Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy. Radiother Oncol 27: 117–122PubMedCrossRefGoogle Scholar
  13. Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin’s disease: International prognostic factors project on advanced Hodgkin’s disease. N Engl J Med 339: 1506–1514PubMedCrossRefGoogle Scholar
  14. Kapp DS, Fisher D, Gutierrez E, Kohorn IE, Schwartz PE (1983) Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariate analysis of the effect of age, stage, histology, and blood counts on survival. Int J Radiat Oncol Biol Phys 9: 445–455PubMedCrossRefGoogle Scholar
  15. Lee WR, Berkey B, Marcial V, Fu KK, Cooper JS, Vikram B, Coia L, Rotman M, Ortiz H (1998) Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85–27. Int J Radiat Oncol Biol Phys 42: 1069–1075PubMedCrossRefGoogle Scholar
  16. Logsdon MD, Eifel PJ (1999) FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43: 763–775PubMedCrossRefGoogle Scholar
  17. Oehler W, Fischer J, Merkle K (1990) Beeinflußt der initiale Hämoglobinwert die Primärtumorreaktion? Eine Untersuchung an 264 bestrahlten Bronchialkarzinomen. Radiobiol Radiother 31: 325–331Google Scholar
  18. Overgaard J (1988) The influence of hemoglobin concentrations on the response to radiotherapy. Scand J Clin Lab Invest 48: 49–53Google Scholar
  19. Pedersen D, Sogaard H, Overgaard J, Bentzen SM (1995) Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol 34: 787–795PubMedCrossRefGoogle Scholar
  20. Quilty PM, Duncan W (1986) The influence of the hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation. Int J Radiat Oncol Biol Phys 12: 1735–1742PubMedCrossRefGoogle Scholar
  21. Rudat V, Dietz A, Schramm O, Conradt C, Maier H, Flentje M, Wannenmacher M (1999) Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 53: 119–125PubMedCrossRefGoogle Scholar
  22. Stadler P, Becker A, Feldmann HJ, Dunst J, Molls M (1999) Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44: 749–754PubMedCrossRefGoogle Scholar
  23. Tarnawski R, Skladowski K, Maciejewski B (1997) Prognostic value of hemoglobin concentration in radiotherapy for cancer of the supraglottic larynx. Int J Radiat Oncol Biol Phys 38: 1007–1011PubMedCrossRefGoogle Scholar
  24. Thomlinson RH, Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9: 539–549PubMedCrossRefGoogle Scholar
  25. Van Acht MJ, Hermans J, Boks DE, Leer JW (1992) The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 23: 229–235PubMedCrossRefGoogle Scholar
  26. Wagner W, Hermann R, Hartlapp J, Esser E, Christoph B, Müller M, Krech R, Koch O (2000) Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther Onkol 176: 73–80PubMedCrossRefGoogle Scholar
  27. Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell Russell A, Komaki R, Lee JS (2000) Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys 48: 1475–1482PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2002

Authors and Affiliations

  1. 1.Department of Radiation OncologyMartin-Luther-University Halle-WittenbergHalleGermany
  2. 2.Department of Radiation OncologyTechnical University MunichMunichGermany

Personalised recommendations